DA32 Life Science Tech Acquisition Corp. (DALS)

NASDAQ: DALS · IEX Real-Time Price · USD
0.00 (0.00%)
Jan 27, 2023, 12:00 AM EST - Market open
Market Cap 258.30M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 25.65M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3
Open 10.02
Previous Close 10.07
Day's Range 10.02 - 10.08
52-Week Range 9.59 - 10.61
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About DALS

DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Jul 28, 2021
Country United States
Stock Exchange NASDAQ
Ticker Symbol DALS
Full Company Profile

Financial Performance

Financial Statements


DA32 Life Science Tech Acquisition Corp., Sponsored by Deerfield, Arch Venture Partners and Section 32, Announces Pricing of $200 Million Initial Public Offering

NEW YORK--(BUSINESS WIRE)--DA32 Life Science Tech Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 20,000,000 shares of Class A common stock at a price o...

1 year ago - Business Wire